Financial News

Recent Quotes
My Watchlist
Indicators
Motherlode Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Aimmune Therap (NQ: AIMT )

34.49 USD UNCHANGED
Last Price Updated: 7:11 PM EDT, Oct 12, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Aimmune Therap

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Why Tilray, Fortuna Silver Mines, and Aimmune Therapeutics Jumped Today
These stocks managed to avoid the market's broad sell-off. 
Tags Market News FSM BUD
From Motley Fool
Noteworthy Thursday Option Activity: PYPL, UAL, AIMT
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in PayPal Holdings Inc (PYPL), where a total of 57,358 contracts have traded so far,... 
Tags Stocks
From Market News Video
Mid-Afternoon Market Update: Dow Tumbles 400 Points; DBV Technologies Shares Plummet
Toward the end of trading opening Thursday, the Dow traded down 1.71 percent to 22,923.29 while the NASDAQ declined 1.62 percent to ... 
Tags Mid/Afternoon Market Update News CIG
From Benzinga
46 Stocks Moving In Thursday's Mid-Day Session
Gainers Inpixon (NASDAQ: INPX) shares climbed 57.1 percent to $4.6968 after the company announced it is on track to ship record ... 
Tags SHLO IMMU PLXP
From Benzinga
Mid-Day Market Update: Crude Oil Down Over 3%; Agenus Shares Spike Higher
Midway through trading opening Thursday, the Dow traded down 0.57 percent to 23,189.82 while the NASDAQ declined 0.4 percent to ... 
Tags News MNKD DBVT
From Benzinga
Mid-Morning Market Update: Markets Mostly Lower; Walgreens Earnings Top Expectations
Following the market opening Thursday, the Dow traded down 0.38 percent to 23,235.56 while the NASDAQ climbed 0.18 percent to 6,649.06. ... 
Tags News DBVT Benzinga
From Benzinga
Sell-Side Slashes DBV Tech Price Targets After Withdrawal Of BLA For Peanut Allergy Immunotherapy
DBV TECHNOLOGIE/S ADR (NASDAQ: DBVT) shares werelosing more than half of their value in Thursday trading following an update on ... 
Tags Biotech Price Target Analyst Color
From Benzinga
The Daily Biotech Pulse: AbbVie Halts Lung Cancer Trial, Oncomed Merges With Mereo, Momenta Offering
Here's a roundup of top developments in the biotech space over the past 48 hours. Scaling The Peak (Biotech stocks hitting ... 
Tags JNJ XBI IBB
From Benzinga
The Daily Biotech Pulse: ASH Presentations Take The Spotlight, Eiger Gets A New CFO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech stocks hitting ... 
Tags NTEC PFE Benzinga
From Benzinga
Benzinga's Top Upgrades, Downgrades For December 3, 2018
Top Upgrades Bank of America upgraded Caterpillar Inc. (NYSE: CAT) from Neutral to Buy. Caterpillar shares rose 4.4 percent to ... 
Tags TKR top upgrades AVGO
From Benzinga
The Daily Biotech Pulse: EC Nod For Shire, Mirati Gets FDA Clearance For Cancer Drug Trials, PhaseBio's First Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech stocks hitting ... 
Tags ALLK LLY FDA
From Benzinga
How The Pieces Add Up: PRFZ Headed For $150
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Swiss stocks - Factors to watch on Nov. 29
Here are some of the main factors that may affect Swiss stocks on Thursday: 
Tags companyNews
From Reuters: Company News
First Week of AIMT January 2019 Options Trading
Investors in Aimmune Therapeutics Inc (AIMT) saw new options begin trading this week, for the January 2019 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AIMT... 
Tags Stocks
From Market News Video
AIMT: Insiders vs. Shorts
The most recent short interest data was recently released for the 10/31/2018 settlement date, and Aimmune Therapeutics Inc (AIMT) is one of the most shorted stocks of the Russell 3000, based on 14.17... 
Tags Stocks
From Market News Video
51 Biggest Movers From Yesterday
Gainers Cesca Therapeutics Inc (NASDAQ: KOOL) gained 51.32 percent to close at $0.46 on Monday after the company announced receipt ... 
Tags SGRP FBIO SNOA
From Benzinga
Here's Why Aimmune Therapeutics Closed Down 11.2% After Publishing Its "Landmark" Clinical Trial
Balancing efficacy and safety is hard. 
Tags AIMT Market News
From Motley Fool
Biotech Slides As Investors Digest Results Of Peanut-Allergy Test
Aimmune Therapeutics fell as investors digested a study testing its oral immunotherapy in children with life-threatening peanut allergies. Aimmune stock lost more than 7% by midday. 
From Investor's Business Daily
35 Stocks Moving In Monday's Mid-Day Session
Gainers Akers Biosciences Inc (NASDAQ: AKER) shares jumped 58.5 percent to $1.95 after the company announced it is evaluating ... 
Tags PCG Mid/Day Gainers EVI
From Benzinga
22 Stocks Moving In Monday's Pre-Market Session
Gainers Leju Holdings Limited (NYSE: LEJU) rose 32 percent to $2.23 in pre-market trading after the company reported Q3 ... 
Tags MFGP XEC ACHC
From Benzinga
UPDATE 2-Nestle raises stake in food allergy drug developer Aimmune
The health science arm of Nestle SA will pay $98 million to raise its stake in Aimmune Therapeutics Inc, the drug developer said, as it prepares to submit a marketing application for its peanut allergy... 
Tags companyNews
From Reuters: Company News
UPDATE 1-Nestle raises stake in food allergy drug developer Aimmune
The health science arm of Nestle SA will pay $98 million to raise its stake in Aimmune Therapeutics, as the drug developer prepares to submit a marketing application for its peanut allergy treatment by... 
Tags companyNews
From Reuters: Company News
Nestle raises stake in food allergy drug developer Aimmune
The health science unit of Nestle SA would pay $98 million to increase its stake in Aimmune Therapeutics Inc, the drug developer for food allergies said on Monday. 
Tags companyNews
From Reuters: Company News
Aimmune Therapeu Rising on Above-Average Volume, Consistent With Trend (AIMT)
Aimmune Therapeu's stock is up 11.8% to $33.83 on heavy trading volume. Approximately 536,000 shares have changed hands today vs. average 30-day volume of 437,000 shares. Unusually high... 
From Comtex SmarTrend® News Briefs
76 Biggest Movers From Yesterday
Gainers 1-800-FLOWERS.COM, Inc. (NASDAQ: FLWS) shares surged 31.1 percent to close at $13.70 after reporting upbeat Q1 ... 
Tags RFP Movers ATTU
From Benzinga
Bullish Moving Average Cross by Aimmune Therapeu (AIMT)
Today, shares of Aimmune Therapeu (NASDAQ:AIMT) have advanced above their 10-day MA of $27.09 on a volume of 529K shares. Swing traders may find an opportunity for a long... 
From Comtex SmarTrend® News Briefs
Implied JKJ Analyst Target Price: $198
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
With life-threatening food allergies on the rise, drug companies ramp up new approaches
Allergies are on the rise and researchers are trying new methods to help combat potentially life threatening reactions. 
Tags Health care industry DBV Technologies SA Business
From CNBC.com News
XBI's Holdings Imply 46% Gain Potential
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Noteworthy Thursday Option Activity: AIMT, IAC, WFC
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Aimmune Therapeutics Inc (AIMT), where a total volume of 3,289 contracts has been... 
Tags Stocks
From Market News Video
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback